Full Text View
Tabular View
No Study Results Posted
Related Studies
The Renin-Angiotensin System in Essential Hypertension
The recruitment status of this study is unknown because the information has not been verified recently.
Verified May 2007 by St George's, University of London.
Recruitment status was  Recruiting
Study NCT00141583   Information provided by St George's, University of London

First Received on August 31, 2005.   Last Updated on May 10, 2007   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Hypertension
More general conditions related to this trial
Cardiovascular Diseases
Vascular Diseases
Interventions listed in this trial
Enalapril 20 mg bd
Candesartan 8 mg bd
Additional drug interventions recognized in this trial
Angiotensin Receptor Antagonists
Candesartan
Candesartan cilexetil
Enalapril
More general drug interventions related to this trial
Angiotensin II Type 1 Receptor Blockers
Angiotensin-Converting Enzyme Inhibitors
Antihypertensive Agents
Cardiovascular Agents
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Protease Inhibitors
Therapeutic Uses
Sponsors listed in this trial
St George's, University of London


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services